ArticleThe Journal of experimental medicine2010

Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression.

Jörn C Albring et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.